Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317664 · ClinicalTrials.gov registry record · Phase 3
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
A Phase 3 study of Communication and Recidivism, sponsored by Ginger Yang.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04317664: Completed Phase 3 study of Communication and Recidivism, sponsored by Ginger Yang.
NCT04317664 is a Phase 3 study of Communication and Recidivism that has completed, run by Ginger Yang. The registered enrollment target is 240 participants, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04317664, a Phase 3 study of Communication and Recidivism, has completed, sponsored by Ginger Yang.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effects of an in-vehicle driving feedback technology, with and without parent communication training, on risky driving events, unsafe driving behaviors, and subsequent traffic violations among teens who have recently received a moving traffic violation.
Primary Outcome
Risky driving events are continuously monitored for teens (240) across all three groups using an in-vehicle device and smartphone app. The system automatically detects and records driving events, including hard braking (≤ -0.45 g-force) sudden acceleration (\> 0.35 g-force), speeding (\>10 miles over the posted speed limit), and speed \>75 mph. Event rates are calculated as the number of risky driving events per 1,000 miles driven.
Conditions Studied
Interventions
- COMBINATION_PRODUCT In-vehicle device
- BEHAVIORAL Parent Communication
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 3 |
What the finished NCT04317664 record still lists
NCT04317664 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (83% lower).
The record links to 4 conditions, with Communication appearing as the primary indexed condition, and to 2 interventions - of which In-vehicle device is the first listed.
NCT04317664 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04317664 about?
NCT04317664 is a clinical study titled "Intervention to Improve Driving Practices Among High-Risk Teen Drivers". The purpose of this study is to test the effects of an in-vehicle driving feedback technology, with and without parent communication training, on risky driving events, unsafe driving behaviors, and subsequent traffic violations among teens who have recently received a moving traffic violation.
What is the current status of trial NCT04317664?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2020-09-28. Estimated completion is 2025-12-31.
What conditions does trial NCT04317664 study?
This clinical trial studies the following conditions: Communication, Recidivism, Drive, Feedback, Psychological.
What interventions are being tested in trial NCT04317664?
The interventions under investigation include: In-vehicle device (COMBINATION_PRODUCT), Parent Communication (BEHAVIORAL).
Who is sponsoring clinical trial NCT04317664?
This trial is sponsored by Ginger Yang, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04317664 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04317664's enrollment target sits among peer trials
240 21st of 34 higher than 14 of 34 other Communication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Teen Driving Translation Study (NIH)
RECRUITING · Phase 3
-
AI-Driven Consent Simplification Study
RECRUITING
-
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
RECRUITING · NA
-
Communication Strategies to Increase HPV Vaccination Intention
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI